Page 67 - Sohini Das

India has registered over 520,000 Covid-19 deaths in all: CRS report

Covid-19 deaths grew in 2021 compared to 2020

One confirmed XE case in India, no reports of clusters in country: INSACOG

In the bulletin for April 18 and 25, INSACOG mentions that one case of coronavirus XE varient has been confirmed in the country.

Ahead in curbing Covid-19 pandemic, India must monitor now: Experts

One of the few to contain Omicron well, it has seen stronger peaks followed by declines

NTAGI meet this week to review vaccine data for 5-12 age group

A senior government official had told Business Standard last week that so far there was no scientific evidence to expand the vaccination programme to young children

Centre urges states to take action on heat wave-related illnesses

In a communication to all chief secretaries of states and UTs, Union Health secy Rajesh Bhushan has sought daily surveillance reports on illnesses shared with NCDC

Non-Covid drugs and vaccines likely to get fast-track approval too

A senior CDSCO official confirmed that there are plans to adopt the best practices used during the Covid-19 pandemic for non-Covid19 drugs too

Eyeing over 15% market share in US for insulin Glargine: Shreehas Tambe

The geopolitical incidents of the recent past as well as the pandemic have not really helped cost pressure: Tambe

Covid vaccination of eligible children a priority, PM Modi tells CMs

Special campaigns needed in schools; parents worried about increased number of cases

Dr Batra's to double clinic count in FY23 on spike in homoeopathy demand

Eyes 225 centres, entry into smaller towns; Firm says clinics are back to pre-Covid-19 footfall levels, with 30% YoY growth in patients in FY22

Pfizer's anti-Covid pill Paxlovid could be available in India next week

This assumes significance as Covid cases are on the rise in the country, especially in the National Capital Region (NCR)

Covid-19: Omicron BA.2.12.1 has mutation akin to Delta, says virologist

Doctors say Covid cases rising, but not very severe patients yet

Awareness holds key to success of AYUSH mark, says industry

PM Modi had said that India would soon introduce the AYUSH mark, which will give authenticity to quality AYUSH products of the country.

Omicron variant found in NCR, likely to have caused spike in Covid cases

BA.2.12.1 is a variant of the virus's Omicron strain and was found in 60% of total samples tested in Delhi

Indian drug firms get a shot in the arm in $12-bn Australian drug market

India has over 750 USFDA approved plants and over 4000 products which are approved by either the US or EU or any other stringent regulator.

Covid-19 cases spike across India; Delhi brings back mask rule

233 out of 727 districts in India report rise in positivity rate between April 16 and 19

Cost pressure likely to weigh on pharma companies' margins in Q4

Among Indian firms, Edelweiss feels that Cipla (respiratory) and Sun Pharma (specialty) are better placed to tide the price erosion

Ocugen to commercialise Covaxin in Mexico, working on US market too

Covaxin has EUA in Mexico for use in adults; data submitted for EUA for children aged 2-18 years

Covid concerns return with cases on the rise; DDMA may make masks mandatory

As on April 16, Delhi-NCR accounted for 52.5 per cent of the country's total cases - up from 11.8 per cent on April 1

Dip in demand for Covid medicines takes a toll on drug sales in March

Covid related drugs contributed 40% of the pharma market last year

Covid-19: Zydus gets SEC approval for two-dose regimen of ZyCov-D

Zydus to conduct mixing trials to test vax efficacy after two shots of Covishield/Covaxin